• Explore /
  • Poster
  • / A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).

A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).

Abstract Poster

Authors

Taofeek Owonikoko

Taofeek Kunle Owonikoko

Emory University, Atlanta, GA

Taofeek Kunle Owonikoko , Kristin Ann Higgins , Zhengjia Chen , Chao Zhang , Rathi Narayana Pillai , Conor Ernst Steuer , Nabil F. Saba , Suchita Pakkala , Dong Moon Shin , Guojing Zhang , Shuhua Wang , Mohammed S Hossain , Tyler Beardslee , Anne Engelhart , Janine Revenig , Fadlo Khuri , Walter John Curran, Jr. Jr., Sagar Lonial , Edmund K. Waller , Suresh S. Ramalingam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02701400

Citation

J Clin Oncol 37, 2019 (suppl; abstr 8515)

DOI

10.1200/JCO.2019.37.15_suppl.8515

Abstract #

8515

Poster Bd #

271

Abstract Disclosures

Similar Posters

First Author: Maria M Rubinstein

First Author: Jenny F. Seligmann

First Author: Luchia Andemicael

First Author: Konrad Friedrich Klinghammer